Evidence map›Paper›PMID 34923606›Full record

ArticleBulletin of mathematical biology2021

Correction to: Mathematical Modelling of Alternative Pathway of Complement System.

Suruchi Bakshi, Fraser Cunningham, Eva-Maria Nichols, Marta Biedzka-Sarek, Jessica Neisen, Sebastien Petit-Frere, Christina Bessant, Loveleena Bansal, Lambertus A Peletier, Stefano Zamuner and 1 more

Abstract readPublished Erratum
In one paragraph

Article in Bulletin of mathematical biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Suruchi BakshiDivision of Systems Biomedicine and Pharmacology, LACDR, Leiden University, P.O. Box 9502, 2300 RA, Leiden, The Netherlands. suruchi.bakshi@certara.com.ORCID http://orcid.org/0000-0002-7767-1705
Fraser CunninghamCytokine, Chemokine and Complement DPU, Immunoinflammation TA Unit, GSK, Stevenage, UK.
Eva-Maria NicholsCytokine, Chemokine and Complement DPU, Immunoinflammation TA Unit, GSK, Stevenage, UK.
Marta Biedzka-SarekCytokine, Chemokine and Complement DPU, Immunoinflammation TA Unit, GSK, Stevenage, UK.
Jessica NeisenCytokine, Chemokine and Complement DPU, Immunoinflammation TA Unit, GSK, Stevenage, UK.
Sebastien Petit-FrereCytokine, Chemokine and Complement DPU, Immunoinflammation TA Unit, GSK, Stevenage, UK.
Christina BessantCytokine, Chemokine and Complement DPU, Immunoinflammation TA Unit, GSK, Stevenage, UK.
Loveleena BansalComputational and Modelling Sciences, Platform Technology Sciences, GSK, Collegeville, Pennsylvania, USA.
Lambertus A PeletierMathematical Institute, Leiden University, P.O. Box 9512, 2300 RA, Leiden, The Netherlands.
Stefano ZamunerClinical Pharmacology, Modelling and Simulation, GSK, Stevenage, UK.
Piet H van der GraafDivision of Systems Biomedicine and Pharmacology, LACDR, Leiden University, P.O. Box 9502, 2300 RA, Leiden, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34923606
PMCPMC9172817

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.